相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinically Isolated Brainstem Progressive Multifocal Leukoencephalopathy: Diagnostic Challenges
Faisal Khan et al.
AMERICAN JOURNAL OF CASE REPORTS (2022)
Brainstem progressive multifocal leukoencephalopathy
Gautier Breville et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease
Irene Cortese et al.
NATURE REVIEWS NEUROLOGY (2021)
Ibrutinib treatment of mantle cell lymphoma complicated by progressive multifocal leukoencephalopathy
Kristina Mosna et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2020)
Improving detection of JC virus by ultrafiltration of cerebrospinal fluid before polymerase chain reaction for the diagnosis of progressive multifocal leukoencephalopathy
Kazuo Nakamichi et al.
BMC NEUROLOGY (2019)
Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia
Charles L. Bennett et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
T cell deficiencies as a common risk factor for drug associated progressive multifocal leukoencephalopathy
Dejan Pavlovic et al.
IMMUNOBIOLOGY (2018)
Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned (vol 17, pg 467, 2018)
E. O. Major et al.
LANCET NEUROLOGY (2018)
Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis
Martijn T. Wijburg et al.
JAMA NEUROLOGY (2018)
Ibrutinib Use Complicated by Progressive Multifocal Leukoencephalopathy
David Hsiehchen et al.
ONCOLOGY (2018)
Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned
Eugene O. Major et al.
LANCET NEUROLOGY (2018)
Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review
Chandrashekar Bohra et al.
CANCER CONTROL (2017)
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia
Mathias Lutz et al.
CANCER RESEARCH AND TREATMENT (2017)
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Michail S. Lionakis et al.
CANCER CELL (2017)
Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia
Anne Wanquet et al.
BLOOD (2016)
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system
Dennis W. Raisch et al.
EXPERT OPINION ON DRUG SAFETY (2016)
The efficacy of ibrutinib in the treatment of Richter syndrome
Mazie Tsang et al.
BLOOD (2015)
Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants
Caroline F. Ryschkewitsch et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section
Joseph R. Berger et al.
NEUROLOGY (2013)
Mirtazapine Use in Human Immunodeficiency Virus-Infected Patients With Progressive Multifocal Leukoencephalopathy
Deanna Cettomai et al.
ARCHIVES OF NEUROLOGY (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells
G Görgün et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy
P Kiewe et al.
LEUKEMIA & LYMPHOMA (2003)
Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside
AJ Aksamit
JOURNAL OF NEUROVIROLOGY (2001)
分享论文
